139 related articles for article (PubMed ID: 35202797)
1. Inhalable cryptotanshinone spray-dried swellable microparticles for pulmonary fibrosis therapy by regulating TGF-β1/Smad3, STAT3 and SIRT3 pathways.
Wang X; Wan W; Lu J; Zhang Y; Quan G; Pan X; Wu Z; Liu P
Eur J Pharm Biopharm; 2022 Mar; 172():177-192. PubMed ID: 35202797
[TBL] [Abstract][Full Text] [Related]
2. Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways.
Zhang Y; Lu W; Zhang X; Lu J; Xu S; Chen S; Zhong Z; Zhou T; Wang Q; Chen J; Liu P
Pharmacol Res; 2019 Sep; 147():104307. PubMed ID: 31181334
[TBL] [Abstract][Full Text] [Related]
3. Inhalable FN-binding liposomes or liposome-exosome hybrid bionic vesicles encapsulated microparticles for enhanced pulmonary fibrosis therapy.
Wang X; Wan W; Lu J; Liu P
Int J Pharm; 2024 May; 656():124096. PubMed ID: 38583821
[TBL] [Abstract][Full Text] [Related]
4. Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needs.
Saber S; Nasr M; Kaddah MMY; Mostafa-Hedeab G; Cavalu S; Mourad AAE; Gaafar AGA; Zaghlool SS; Saleh S; Hafez MM; Girgis S; Elgharabawy RM; Nader K; Alsharidah M; Batiha GE; El-Ahwany E; Amin NA; Elagamy HI; Shata A; Nader R; Khodir AE
Biomed Pharmacother; 2022 Apr; 148():112731. PubMed ID: 35220029
[TBL] [Abstract][Full Text] [Related]
5. Effects of L-leucine on the properties of spray-dried swellable microparticles with wrinkled surfaces for inhalation therapy of pulmonary fibrosis.
Wang X; Wan W; Lu J; Quan G; Pan X; Liu P
Int J Pharm; 2021 Dec; 610():121223. PubMed ID: 34710541
[TBL] [Abstract][Full Text] [Related]
6. Efficient pulmonary fibrosis therapy via regulating macrophage polarization using respirable cryptotanshinone-loaded liposomal microparticles.
Wang X; Wan W; Zhang J; Lu J; Liu P
J Control Release; 2024 Feb; 366():1-17. PubMed ID: 38154539
[TBL] [Abstract][Full Text] [Related]
7. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression.
Zhang HX; Li YN; Wang XL; Ye CL; Zhu XY; Li HP; Yang T; Liu YJ
Pulm Pharmacol Ther; 2019 Aug; 57():101803. PubMed ID: 31085231
[TBL] [Abstract][Full Text] [Related]
8. Danggui Buxue Tang ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting transforming growth factor-β1/Smad3/ plasminogen activator inhibitor-1 signaling pathway.
Wang J; Fang C; Wang S; Fang F; Chu X; Liu N; Lu C; Wang S; Li W
J Tradit Chin Med; 2020 Apr; 40(2):236-244. PubMed ID: 32242389
[TBL] [Abstract][Full Text] [Related]
9. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C
PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091
[TBL] [Abstract][Full Text] [Related]
10. Protective Effect of Ginsenoside Rg1 on Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of Caveolin-1 and TGF-β1 Signal Pathway.
Zhan H; Huang F; Ma W; Zhao Z; Zhang H; Zhang C
Biol Pharm Bull; 2016; 39(8):1284-92. PubMed ID: 27476938
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y
Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163
[TBL] [Abstract][Full Text] [Related]
12. Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice.
Guo J; Fang Y; Jiang F; Li L; Zhou H; Xu X; Ning W
Eur J Pharmacol; 2019 Dec; 864():172712. PubMed ID: 31586469
[TBL] [Abstract][Full Text] [Related]
13. Edaravone attenuates lipopolysaccharide-induced acute respiratory distress syndrome associated early pulmonary fibrosis via amelioration of oxidative stress and transforming growth factor-β1/Smad3 signaling.
Wang X; Lai R; Su X; Chen G; Liang Z
Biochem Biophys Res Commun; 2018 Jan; 495(1):706-712. PubMed ID: 29102631
[TBL] [Abstract][Full Text] [Related]
14. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
15. Effect of Renshen Pingfei Decoction, a traditional Chinese prescription, on IPF induced by Bleomycin in rats and regulation of TGF-β1/Smad3.
Chen F; Wang PL; Fan XS; Yu JH; Zhu Y; Zhu ZH
J Ethnopharmacol; 2016 Jun; 186():289-297. PubMed ID: 27013092
[TBL] [Abstract][Full Text] [Related]
16. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
17. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
18. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
20. Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice by downregulating collagen deposition.
Lu GX; Bian DF; Ji Y; Guo JM; Wei ZF; Jiang SD; Xia YF; Dai Y
Phytother Res; 2014 Aug; 28(8):1224-31. PubMed ID: 24458872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
